Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (36)
COVID-19 (13)
Type
Type
Guidance (1987)
NICE advice (317)
Quality standard (196)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (18)
Cancer service guidelines (8)
Clinical guidelines (226)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (33)
Highly specialised technologies guidance (30)
Interventional procedures guidance (612)
Medical technologies guidance (66)
Medicines practice guidelines (5)
NICE guidelines (336)
Public health guidelines (56)
Safe staffing guidelines (2)
Social care guidelines (70)
Technology appraisal guidance (860)
Advice programme
Advice programme
Evidence summaries (67)
Medtech innovation briefings (250)
Apply filters
Showing 21 to 30 of 2500
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Bed frames for adults in acute medical or surgical hospital wards: late-stage assessment
HTE33
27 August 2025
27 August 2025
Pembrolizumab with carboplatin and paclitaxel for untreated primary advanced or recurrent endometrial cancer
TA1092
27 August 2025
27 August 2025
Transcatheter heart valves for transcatheter aortic valve implantation to treat aortic stenosis: late-stage assessment
HTE31
21 August 2025
21 August 2025
Tarlatamab for extensive-stage small-cell lung cancer after 2 or more treatments
TA1091
20 August 2025
20 August 2025
Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma
TA1090
19 August 2025
19 August 2025
Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and over
TA1088
13 August 2025
13 August 2025
Sacituzumab govitecan for treating hormone receptor-positive HER2-negative metastatic breast cancer after 2 or more treatments (terminated appraisal)
TA1089
13 August 2025
13 August 2025
Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive HER2-negative early breast cancer at high risk of recurrence
TA1086
6 August 2025
6 August 2025
Betula verrucosa for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollen
TA1087
6 August 2025
6 August 2025
Single-step scaffold insertion for repairing symptomatic chondral knee defects
IPG793
3 September 2024
5 August 2025
Previous page
1
2
Current page
3
4
5
…
250
Page
3
of
250
Next page
Results per page
10
25
50
All
Back to top